MARKET

NSTM

NSTM

Novelstem Intl Corp
OTCPK
0.020
-0.000
-0.50%
Closed 14:56 05/23 EDT
OPEN
0.039
PREV CLOSE
0.020
HIGH
0.039
LOW
0.020
VOLUME
495.00K
TURNOVER
10.59K
52 WEEK HIGH
0.060
52 WEEK LOW
0.0077
MARKET CAP
937.63K
P/E (TTM)
-0.2899
1D
5D
1M
3M
1Y
5Y
1D
Based on the provided financial report articles, I generated the title for the article: "NewStem Ltd. Quarterly Report (Q1 2025)" Please note that the title may not be exact, as the provided text does not contain a clear title. However, based on the content, I inferred that the article is a quarterly report for NewStem Ltd. for the first quarter of 2025.
Press release · 4d ago
Weekly Report: what happened at NSTM last week (0512-0516)?
Weekly Report · 5d ago
NovelStem International Delays Q1 2025 Report Filing
TipRanks · 05/15 20:17
Weekly Report: what happened at NSTM last week (0505-0509)?
Weekly Report · 05/12 10:46
Weekly Report: what happened at NSTM last week (0428-0502)?
Weekly Report · 05/05 10:48
Weekly Report: what happened at NSTM last week (0421-0425)?
Weekly Report · 04/28 10:55
Weekly Report: what happened at NSTM last week (0414-0418)?
Weekly Report · 04/21 10:55
Weekly Report: what happened at NSTM last week (0407-0411)?
Weekly Report · 04/14 10:46
More
About NSTM
NovelStem International Corp. is a development-stage biotechnology holding company focused on stem cell-based technology. The Company's primary assets are NewStem Ltd (NewStem) and NetCo Partners (NetCo). NewStem focuses on the development and commercialization of diagnostic technology that can predict patients’ anti-cancer drug resistance, allowing for targeted cancer treatments and the potential to reduce resistance to chemotherapy. NewStem is principally focused on utilizing proprietary human Pluripotent Stem Cells (hPSCs) and Haploid human Pluripotent Stem Cells (HhPSCs) in the development of diagnostic and therapeutic products in oncology. Its NewStem Software Diagnostic Device (NSDD) is a bioinformatics-based software medical device platform that provides oncologists with information regarding the presence of mutations in tumors, which may confer patient resistance to certain anti-cancer drugs. NetCo is a media business interest which owns Net Force, a book publishing franchise.

Webull offers Novelstem International Corp stock information, including OTCPK: NSTM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NSTM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NSTM stock methods without spending real money on the virtual paper trading platform.